S.N. Vyshelesski Institute of Experimental Veterinary

220063, Briketa ul., 28, Мinsk, Belarus Тel./fax: +375 17 517 32 61 E-mail: bievm@tut.by

Veterinary preparations "Bravidefen", "Metaphytohit", "Sapofor"









Linked profile in other language
Alla Larkova
S.N. Vyshelesski Institute of Experimental Veterinary offers consumers veterinary drugs "Bravidefen", "Metafitokhit", "Sapofor" under a manufacturing agreement and is looking for partners interested in a distribution services agreement.
The drug "Bravidefen" was developed on the basis of a nanostructured substance of a natural phytosterol of a number of brassinosteroids and enhances the synthesis of cytokines and antibody production (it has an absolute novelty). It is used as an immunostimulating agent for prophylactic purposes in farms that are unfavorable and threatened by Newcastle disease and infectious avian laryngotracheitis.

The preparation "Metaphytochit" contains probiotics, phytolectins, chitosan and helps to reduce the case by 15% ("PhytoChitodez" (Russia) - 7.5..5.7%), shorten the duration of treatment, increases therapeutic activity. It is used for the prevention and treatment of dysbiotic conditions of various etiologies and their consequences in farm animals, correction and stabilization of the composition of the autoflora of the gastrointestinal tract, normalization of intestinal digestion, stimulation of immunity.

"Sapofor" is used as an immunostimulant based on triterpene saponins for the prevention and treatment of subclinical mastitis, as well as for the complex therapy and prevention of infectious diseases of various etiologies in calves and piglets. The drug increases the activity of specific immunity factors and enhances the production of antibodies when vaccinated; reduces the content of somatic cells in milk by 3.0..3.5 times; increases the average daily milk yield up to 25 liters per cow with a milk marketability of 95..96%.

More "Sapofor" (in Russian)
Advantages and Innovations
The prophylactic efficacy of the drug "Bravidefen" is 85..95%, economic efficiency - 2.9 rub./rub. costs.

Therapeutic efficacy of the drug "Metaphytohit" - 90..92%, economic efficiency - 3.7 rub./rub. costs.

The economic efficiency of the drug "Sapofor" - not less than 6 rub./rub. costs.
Stage of development
Already on the market
Comments regarding stage of development
Specifications were approved for the entire group of drugs in 2018.
Funding source
State budged
IPR status
Exclusive rights
Secret know-how
Sector group

Organization information

R&D institution
Year established
NACE keywords
A.01.61 - Support activities for crop production
M.72.11 - Research and experimental development on biotechnology
M.74.90 - Other professional, scientific and technical activities n.e.c.
Turnover (in EUR)
Already engaged in transnational cooperation
Additional comments
The high level of development of animal husbandry in the Republic of Belarus is largely ensured by the efforts of veterinary medicine and its scientific and methodological center, which is the Republican Unitary Enterprise “S.N. Vyshelesski Institute of Experimental Veterinary".

Areas of activity of the Institute:
✔ development and improvement of methods for diagnosis, prevention, treatment, measures to combat infectious, parasitic and non-contagious diseases of farm animals, birds, bees;
✔ creation of modern vaccines, highly specific diagnostics, drugs, metabolic correction agents that provide veterinary protection of animals and obtain environmentally friendly livestock products;
✔ provision of scientific and practical assistance to the farms of the republic;
✔ training of highly qualified scientific personnel.

The tasks facing the Institute:
✔ conducting fundamental and applied research in the field of veterinary medicine in accordance with the main directions of economic and social development of the agro-industrial complex of the Republic of Belarus;
✔ conducting fundamental and applied research to study the mechanisms of immunity formation and the development of methods for its directed regulation;
✔ development of forecasts and programs for veterinary medicine;
✔ epizootological monitoring of the most common and parasitic infectious animal diseases, development of short-term and long-term forecasts of their occurrence and degree of manifestation;
✔ development of new and improvement of existing competitive means and methods for the diagnosis, prevention and treatment of infectious, parasitic and non-contagious animal diseases, the creation of integrated systems that ensure the protection of human health, the veterinary welfare of animal husbandry, obtaining environmentally friendly and high sanitary quality livestock products;
✔ isolation and study of the genetic, molecular and biological properties of pathogens of infectious diseases, selection and collection of useful strains that are promising for the creation of diagnosticums and vaccines;
✔ development of technologies for the production of veterinary drugs, vaccines, chemicals, antiparasitic agents.
Languages spoken

Information about partnership

Type of partnership considered
Distribution services agreement
Manufacturing agreement
Type and role of partner sought
Consumers interested in purchasing of the veterinary preparations "Bravidefen", "Metaphytohit", "Sapofor" under a manufacturing agreement.

Partners interested in purchasing of the veterinary preparations "Bravidefen", "Metaphytohit", "Sapofor" under a distribution services agreement .
Type and size of partner sought
> 500
SME 51-250
SME 11-50
SME <= 10
R&D Institution


Views: 1189
Statistics since 13.05.2022 15:41:08